X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (360) 360
hematology (295) 295
male (289) 289
middle aged (288) 288
female (282) 282
aged (252) 252
index medicus (233) 233
adult (218) 218
oncology (197) 197
multiple myeloma (149) 149
treatment outcome (132) 132
survival (130) 130
transplantation (128) 128
prognosis (121) 121
retrospective studies (112) 112
aged, 80 and over (104) 104
multiple myeloma - drug therapy (94) 94
multiple-myeloma (88) 88
amyloidosis (85) 85
therapy (85) 85
care and treatment (84) 84
survival analysis (84) 84
stem-cell transplantation (82) 82
multiple myeloma - mortality (79) 79
chemotherapy (74) 74
stem cells (73) 73
stem cell transplantation (71) 71
immunology (70) 70
transplantation, autologous (70) 70
multiple myeloma - therapy (69) 69
survival rate (67) 67
primary systemic amyloidosis (66) 66
risk factors (61) 61
melphalan (60) 60
diagnosis (58) 58
hematopoietic stem cell transplantation (58) 58
dexamethasone (57) 57
follow-up studies (56) 56
antineoplastic combined chemotherapy protocols - therapeutic use (55) 55
disease-free survival (54) 54
al amyloidosis (53) 53
bortezomib (50) 50
disease progression (49) 49
article (48) 48
abridged index medicus (47) 47
amyloidosis - therapy (47) 47
multiple myeloma - pathology (47) 47
medicine, general & internal (46) 46
patient outcomes (45) 45
amyloidosis - mortality (43) 43
multiple myeloma - diagnosis (43) 43
thalidomide - analogs & derivatives (43) 43
research (41) 41
health aspects (40) 40
monoclonal gammopathy (40) 40
dexamethasone - administration & dosage (39) 39
thalidomide (38) 38
analysis (36) 36
lenalidomide (36) 36
recurrence (36) 36
light-chain amyloidosis (35) 35
combined modality therapy (34) 34
patients (34) 34
thalidomide - administration & dosage (34) 34
time factors (33) 33
antineoplastic agents - therapeutic use (32) 32
cancer (32) 32
high-dose melphalan (32) 32
drug therapy (30) 30
risk (29) 29
thalidomide - therapeutic use (28) 28
bone-marrow transplantation (27) 27
kaplan-meier estimate (27) 27
myeloma (27) 27
prednisone (27) 27
usage (27) 27
high-dose therapy (26) 26
multiple myeloma - genetics (26) 26
peripheral-blood (26) 26
trial (26) 26
amyloidosis - complications (25) 25
undetermined significance (25) 25
amyloidosis - diagnosis (24) 24
brain natriuretic peptide (24) 24
dosage and administration (24) 24
hematopoietic stem cell transplantation - methods (24) 24
multiple myeloma - blood (24) 24
progression (24) 24
randomized-trial (23) 23
staging system (23) 23
thalidomide - adverse effects (23) 23
amyloidosis - pathology (22) 22
autografts (22) 22
plasma cells - pathology (22) 22
remission induction (22) 22
cohort studies (21) 21
criteria (21) 21
antineoplastic combined chemotherapy protocols - adverse effects (20) 20
bone marrow - pathology (20) 20
mortality (20) 20
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 10/2013, Volume 122, Issue 14, pp. 2305 - 2309
Journal Article
BLOOD, ISSN 0006-4971, 06/2014, Volume 123, Issue 26, pp. 4153 - 4153
Journal Article
Journal Article
Blood, ISSN 0006-4971, 07/2010, Volume 116, Issue 1, pp. 2 - 3
Patients with MM have a high risk of VTE. The relationship between MM and ATE is less clear. In this issue of Blood, Libourel and colleagues report a high... 
HEMATOLOGY
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2013, Volume 88, Issue 4, pp. 360 - 376
Journal Article